Clinical Trial Update: Study of Fluoxetine in Autism [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fluoxetine for autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Fluoxetine (Prozac) (Fluoxetine)

Snippet

Sponsor: Neuropharm | Conditions: Autistic Disorder | Phase 3 | Status: COMPLETED